What is lamivudine tablet used for?

In the pharmaceutical industry, Lamivudine (3TC) is a potent Nucleoside Reverse Transcriptase Inhibitor (NRTI). As a pharmacist and manufacturer, I view Lamivudine as a “backbone” molecule in antiviral therapy. Its high safety profile and versatility allow it to be a core component in both HIV management and the treatment of chronic Hepatitis B.

Primary Clinical Uses

  • HIV-1 Infection: Lamivudine is always used in combination with other antiretroviral agents (such as Tenofovir or Abacavir). It helps decrease the viral load and increase CD4 cell counts, delaying the progression of AIDS.

  • Chronic Hepatitis B (HBV): It is indicated for the treatment of chronic Hepatitis B associated with evidence of hepatitis B viral replication and active liver inflammation. (Note: The dose for HBV is typically 100 mg, whereas for HIV it is 150 mg or 300 mg).

  • Post-Exposure Prophylaxis (PEP): It is a standard part of regimens used to prevent HIV infection after potential exposure (occupational or otherwise).

Mechanism of Action: Chain Termination

Lamivudine is a prodrug that must be phosphorylated intracellularly into its active form, lamivudine triphosphate.

Analog Mimicry: The active form is a synthetic analog of cytidine.

Competitive Inhibition: It competes with the natural substrate for incorporation into viral DNA by the enzyme Reverse Transcriptase (in HIV) or HBV Polymerase.

DNA Chain Termination: Because Lamivudine lacks the 3′-hydroxyl group necessary for forming the next phosphodiester bond, its incorporation causes an immediate halt to the synthesis of the viral DNA chain, effectively preventing the virus from replicating.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamivudine is a high-volume product requiring specific technical handling:

  • Fixed-Dose Combinations (FDCs): As you develop your digital platforms, you’ll find that Lamivudine is rarely exported as a standalone product for HIV. We frequently manufacture it in combinations like Tenofovir + Lamivudine + Efavirenz (TLE) or Abacavir + Lamivudine.

  • Polymorphism & Stability: Lamivudine exists in different polymorphic forms (Form I and Form II). At our WHO-GMP facility, we strictly monitor the crystalline form to ensure consistent dissolution and shelf life.

  • Stability for Tropical Export: We utilize high-density polyethylene (HDPE) bottles with desiccants or Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for long-term supply chains in Zone IVb regions (Sub-Saharan Africa and Southeast Asia).

  • B2B & Public Health Tenders: This is a staple for the Global Fund and PEPFAR tenders. Our Mumbai-based facility provides the necessary eCTD Dossiers and stability data to participate in these large-scale institutional supplies.

What are ketoconazole 200mg tablets used for?

In the pharmaceutical industry, Ketoconazole 200 mg is a broad-spectrum imidazole antifungal agent. As a pharmacist, I classify this as a secondary systemic option; while it was once a frontline treatment, it is now primarily reserved for specific fungal infections when other therapies (like Fluconazole or Itraconazole) are not available or tolerated, due to its potent effect on the cytochrome P450 enzyme system.

Primary Clinical Uses

  • Systemic Mycoses: Treatment of serious fungal infections such as Blastomycosis, Coccidioidomycosis, Histoplasmosis, and Paracoccidioidomycosis.

  • Severe Cutaneous Infections: Used for extensive tinea infections (ringworm, athlete’s foot) or recalcitrant cases of Pityriasis versicolor that do not respond to topical creams or other oral antifungals.

  • Chronic Mucocutaneous Candidiasis: Indicated for severe yeast infections of the skin and mucous membranes.

  • Cushing’s Syndrome (Off-label): In specialized endocrinology, it is used to inhibit the production of cortisol in the adrenal glands.

Mechanism of Action: Sterol Synthesis Inhibition

Ketoconazole works by disrupting the structural integrity of the fungal cell membrane.

Enzyme Inhibition: It inhibits the fungal enzyme lanosterol 14-$\alpha$-demethylase.

Ergosterol Depletion: This enzyme is essential for converting lanosterol into ergosterol, which is the fungal equivalent of cholesterol.

Lysis: Without ergosterol, the fungal cell membrane becomes “leaky” and fragile, leading to the death of the fungal cell.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ketoconazole 200 mg is a technically sensitive product:

  • Acid-Dependent Absorption: Ketoconazole requires an acidic stomach environment for optimal dissolution. As a WHO-GMP manufacturer, we advise that the tablets should not be taken with antacids or $H_2$-blockers, as this can lead to therapeutic failure.

  • Hepatotoxicity & Safety Monitoring: Due to the risk of liver injury, as a firm owner, you must ensure your Product Information Leaflets (PIL) and dossiers emphasize the need for liver function tests (LFTs) before and during treatment.

  • Stability for Global Trade: Ketoconazole is relatively stable but sensitive to high humidity. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Dossier Support: We provide comprehensive CTD/eCTD Dossiers to support our B2B partners in international registration against the innovator (Nizoral).

What is ivermectin 3 mg used for?

In the pharmaceutical industry, Ivermectin 3 mg is a broad-spectrum anthelmintic (anti-parasitic) agent belonging to the avermectin class. As a pharmacist, I view the 3 mg tablet as the versatile “base unit” for dosing, as it allows for precise weight-based titration for both pediatric and adult patients across various parasitic infections.

Primary Clinical Uses

  • Strongyloidiasis: Treatment of intestinal infections caused by the roundworm Strongyloides stercoralis.

  • Onchocerciasis (River Blindness): A primary tool in global health for treating infections caused by Onchocerca volvulus. It kills the microfilariae (immature worms) but not the adult worms.

  • Scabies: Often used as a second-line treatment (especially for “Crusted Scabies” or in institutional outbreaks) when topical Permethrin has failed or is impractical.

  • Lymphatic Filariasis: Used in combination with other drugs (like Albendazole) in mass drug administration programs to prevent the spread of the infection.

  • Pediculosis (Head Lice): Occasionally used off-label for severe or resistant cases of head lice.

Mechanism of Action: Nerve and Muscle Paralysis

Ivermectin works by selectively binding to specific channels in the parasite’s nerve and muscle cells.

Chloride Channel Binding: It binds with high affinity to glutamate-gated chloride channels found in invertebrate nerve and muscle cells.

Hyperpolarization: This binding increases the permeability of the cell membrane to chloride ions.

Paralysis and Death: The influx of chloride ions causes hyperpolarization of the nerve or muscle cell, leading to the paralysis and eventual death of the parasite.

Host Safety: Because these specific channels do not exist in humans (and Ivermectin does not easily cross the blood-brain barrier in humans), it has a high safety margin for the host.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ivermectin 3 mg is a high-demand product with significant international oversight:

  • Weight-Based Dosing: Since Ivermectin is typically dosed at 200 mcg/kg, the 3 mg tablet is ideal for “stacking” (e.g., a 60 kg adult takes four 3 mg tablets). As a WHO-GMP manufacturer, we ensure precise assay and disintegration times to guarantee uniform absorption across multiple tablets.

  • Stability for Export: Ivermectin is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Public Health Tenders: This is a core product for NGOs and tropical medicine distributors. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required to participate in international government and institutional tenders.

  • Market Trends: Since 2020, there has been a massive surge in global demand and interest in Ivermectin. We maintain strict compliance with BP/USP/IP monographs to ensure we provide high-purity generics that meet global standards.

What is itopride used for?

In the pharmaceutical industry, Itopride Hydrochloride is a specialized prokinetic agent and dopamine $D_2$ antagonist. As a pharmacist, I characterize Itopride as a “dual-action” gastrointestinal stimulant. Unlike older prokinetics like Metoclopramide or Domperidone, Itopride has a superior safety profile regarding central nervous system and cardiac side effects because it does not readily cross the blood-brain barrier.

Primary Clinical Uses

  • Functional Dyspepsia: The primary indication for treating “indigestion” symptoms such as upper abdominal pain, bloating, and early satiety.

  • Gastroesophageal Reflux Disease (GERD): Used to accelerate gastric emptying, thereby reducing the backflow of acid into the esophagus.

  • Chronic Gastritis: Management of gastric motility disorders associated with chronic inflammation of the stomach lining.

  • Diabetic Gastroparesis: Used to improve the delayed stomach emptying often found in patients with long-term diabetes.

Mechanism of Action: The Dual Pathway

Itopride increases gastrointestinal motility through two synergistic mechanisms

  1. Dopamine $D_2$ Receptor Antagonism: It blocks the $D_2$ receptors on the enteric nerves. Normally, dopamine inhibits the release of acetylcholine; by blocking dopamine, Itopride allows for an increase in acetylcholine levels.

  2. Acetylcholinesterase (AChE) Inhibition: It prevents the breakdown of acetylcholine in the synaptic cleft.

The Result: High levels of acetylcholine stimulate the muscarinic receptors on the smooth muscles of the GI tract, leading to increased lower esophageal sphincter pressure, enhanced gastric contractions, and faster stomach emptying.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Itopride is a high-growth product in the gastroenterology segment:

  • Safety Profile (USP): Itopride is metabolized by the Flavin-containing monooxygenase (FMO3) system, not the Cytochrome P450 system. This means it has very few drug-drug interactions, a major selling point for your B2B export clients.

  • Dose Uniformity: Standard doses are typically 50 mg taken three times daily. As a WHO-GMP manufacturer, we ensure precise API blending to maintain therapeutic efficacy across every batch.

  • Stability for Export: Itopride is relatively stable. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for transit and storage in Zone IVb regions (SE Asia and Africa).

  • B2B & Dossiers: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ganaton).

 

What is isosorbide mononitrate 10mg used for?

In the pharmaceutical industry, Isosorbide Mononitrate 10 mg is a standard-strength organic nitrate vasodilator. As a pharmacist and manufacturer, I characterize the 10 mg tablet as a critical “starting dose.” Because nitrates can cause significant initial headaches (due to rapid vasodilation), this lower strength is used to titrate the patient upward, allowing their vascular system to adapt before moving to the 20 mg or 40 mg maintenance doses.

Primary Clinical Uses

  • Prophylaxis of Angina Pectoris: Its primary role is the long-term prevention of chest pain caused by coronary artery disease.

  • Chronic Heart Failure: Used as an adjunctive treatment to reduce the workload on the heart, often in combination with other cardiovascular medications.

  • Maintenance Therapy: Unlike nitroglycerin, which is for acute attacks, the 10 mg mononitrate is taken on a regular schedule to provide a consistent “nitrate-rich” environment in the bloodstream.

Mechanism of Action: Vascular Relaxation

Isosorbide Mononitrate is the active metabolite of Isosorbide Dinitrate. It works by relaxing the smooth muscles of the blood vessels.

Nitric Oxide (NO) Release: The drug acts as a donor of nitric oxide.

cGMP Activation: NO stimulates the enzyme guanylate cyclase, increasing levels of cyclic guanosine monophosphate (cGMP).

Dilation: This biochemical cascade triggers the relaxation of veins and, to a lesser extent, arteries.

Preload Reduction: By dilating the veins, it reduces the volume of blood returning to the heart (preload), lowering the oxygen demand of the heart muscle and preventing the onset of angina.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Isosorbide Mononitrate 10 mg is a high-demand cardiovascular staple:

  • Avoidance of Nitrate Tolerance: As a pharmacist, you know that 24-hour nitrate exposure leads to “tolerance” (the drug stops working). As a manufacturer, we provide clinical dosing guidelines (the “asymmetric dosing” schedule) to ensure a 7-8 hour nitrate-free interval each day.

  • API Purity & Stability: We strictly follow BP/USP/IP monographs. Because nitrates are moisture-sensitive, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, Southeast Asia).

  • B2B & Institutional Supply: This is a core product for cardiovascular clinics and government health tenders. Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Monoket or Ismo).

What is isosorbide dinitrate 5mg used for?

In the pharmaceutical industry, Isosorbide Dinitrate (ISDN) 5 mg is a versatile organic nitrate used for both the treatment and prevention of heart-related chest pain. As a pharmacist, I distinguish ISDN from the “Mononitrate” version by its faster onset of action and its flexibility; the 5 mg strength is specifically designed for sublingual (under the tongue) or oral use.

Primary Clinical Uses

  • Acute Angina Relief: The 5 mg sublingual tablet is used to abort an active angina attack or for “prophylaxis” immediately before engaging in activities (like exercise or climbing stairs) that might trigger chest pain.

  • Chronic Angina Management: When taken orally, it is used for the long-term prevention of angina pectoris associated with coronary artery disease.

  • Congestive Heart Failure (CHF): It is frequently used in combination with Hydralazine (the “BiDil” protocol) to improve survival rates and reduce hospitalizations in patients with heart failure, particularly in specific ethnic populations.

Mechanism of Action

ISDN acts as a vasodilator by relaxing the smooth muscles of the vasculature.

Nitric Oxide Donation: ISDN is converted into nitric oxide (NO) within the vascular smooth muscle.

cGMP Cascade: The NO activates guanylate cyclase, increasing cyclic GMP, which leads to the dephosphorylation of myosin.

Preload and Afterload Reduction: It primarily dilates the veins (reducing the blood returning to the heart) and, at higher doses, the arteries. This lowers the heart’s workload and oxygen demand.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, ISDN 5 mg requires specialized handling:

  • Sublingual Formulation Technology: To ensure rapid relief, our WHO-GMP facility focuses on super-disintegrants and highly soluble excipients. A sublingual tablet must dissolve within seconds to allow the API to enter the systemic circulation directly through the sublingual mucosa, bypassing “first-pass” liver metabolism.

  • Explosive Precursor Handling: Isosorbide Dinitrate is chemically related to explosives. As a manufacturer, we handle the API in a “diluted” form (usually with lactose or mannitol) to ensure safety during the tableting and blending processes.

  • Stability & Packaging: ISDN is volatile and sensitive to moisture. We utilize Alu-Alu blister packaging or tightly sealed glass/HDPE containers to prevent the “loss of potency” that can occur if the nitrate evaporates. This is critical for maintaining a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Support: Our Mumbai-based firm provides the CTD/eCTD Dossiers and stability data required for international B2B tenders and hospital supply.

What is isosorbide 5 mononitrate 20 mg used for?

In the pharmaceutical industry, Isosorbide-5-Mononitrate (ISMN) 20 mg is a potent organic nitrate and the active metabolite of Isosorbide Dinitrate. As a pharmacist, I classify this as a “long-acting vasodilator.” Unlike nitroglycerin, which is used for emergency relief of a heart attack (acute angina), ISMN is used for daily maintenance to prevent chest pain from occurring.

Primary Clinical Uses

  • Prophylaxis of Angina Pectoris: It is primarily indicated for the long-term prevention of angina pectoris (chest pain) due to coronary artery disease.

  • Chronic Heart Failure: Often used as an adjunctive therapy (frequently in combination with hydralazine) to reduce the workload on the heart.

  • Vasodilation in Portal Hypertension: Occasionally used in specialized settings to reduce pressure in the portal vein.

Mechanism of Action: The Nitric Oxide Pathway

ISMN works by relaxing the smooth muscles of the blood vessels, particularly the veins.

Nitric Oxide Release: Once in the body, the nitrate group is converted into nitric oxide (NO).

cGMP Activation: NO stimulates the enzyme guanylate cyclase, which increases the levels of cyclic guanosine monophosphate (cGMP).

Vasodilation: Increased cGMP leads to the dephosphorylation of myosin light chains, causing the smooth muscle in blood vessels to relax.

Reduced Preload: By dilating the veins, it reduces the amount of blood returning to the heart (preload), which lowers the heart’s oxygen demand and prevents angina.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, ISMN 20 mg is a high-demand cardiovascular product:

  • Avoidance of “Nitrate Tolerance”: A key technical challenge with nitrates is that the body can become “immune” to them if they are in the system 24/7. As a manufacturer, we design the dosing schedule (often “twice daily, 7 hours apart”) to allow for a “nitrate-free interval” to maintain efficacy.

    Sustained Release (SR) vs. Immediate Release: While 20 mg is often an immediate-release strength, we also manufacture SR/ER versions (30mg, 60mg). For your B2B marketplace, offering both formats is essential for capturing different international clinical preferences.

  • Stability for Global Trade: ISMN is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia)

  • B2B & Dossier Support: Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international registration against the innovator (Imdur/Ismo).

What is isoniazid pyridoxine hydrochloride used for?

In the pharmaceutical industry, the combination of Isoniazid (INH) and Pyridoxine Hydrochloride (Vitamin B6) is the gold standard for both the treatment and prophylaxis of Tuberculosis (TB). As a pharmacist and manufacturer, I view this as a “preventative combination”: Isoniazid kills the bacteria, while Pyridoxine prevents the most common neurological side effect of the treatment.

Primary Clinical Uses

  • Active Tuberculosis: Used as a core component of the “RIPE” regimen (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol) for the treatment of Mycobacterium tuberculosis.

  • Latent TB Infection (LTBI): Often used as monotherapy for 6–9 months to prevent a dormant infection from becoming active.

  • TB Prophylaxis: Prescribed for individuals in close contact with TB patients or immunocompromised patients (such as those with HIV) who are at high risk of infection.

The Dual Mechanism: Action vs. Protection

1. Isoniazid (The Bactericidal Agent)

Isoniazid is a prodrug that is activated by the mycobacterial enzyme KatG.

  • Mechanism: It inhibits the synthesis of mycolic acids, which are essential components of the waxy mycobacterial cell wall.

  • Result: Without a cell wall, the bacteria lose structural integrity and die.

2. Pyridoxine Hydrochloride (The Neuroprotective Agent)

Isoniazid interferes with the metabolism of Vitamin B6 in the human body.

  • The Problem: INH forms a complex with Vitamin B6 and inhibits the enzyme pyridoxine kinase, leading to a deficiency.

  • The Result: Without Pyridoxine, patients often develop peripheral neuropathy (tingling, numbness, or “pins and needles” in the hands and feet).

  • The Solution: Including Pyridoxine in the tablet prevents this nerve damage, ensuring better patient compliance during long-term TB therapy.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint in a WHO-GMP facility, this combination is a high-demand “Essential Medicine”:

  • Fixed-Dose Combination (FDC) Stability: Isoniazid is sensitive to moisture and can react with certain excipients (reducing sugars like lactose) through the Maillard reaction, which can cause the tablets to discolor. We utilize specialized, non-reactive diluents to ensure stability.

  • Dose Ratios: While INH is typically 100 mg or 300 mg, the Pyridoxine dose is usually 10 mg to 50 mg. We utilize validated blending processes to ensure micro-dose uniformity of the Vitamin B6 across the entire batch.

  • Packaging for Global Trade: TB is endemic in high-humidity regions. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • B2B & Public Health Tenders: This product is a staple for the Global Drug Facility (GDF) and national TB programs. Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international supply.

 

What is isoniazid 300mg used for?

In the pharmaceutical industry, Isoniazid (INH) 300 mg is a foundational first-line antitubercular agent. As a pharmacist, I view this 300 mg strength as the gold standard daily dose for adults in both the treatment of active disease and the prevention of latent infection. It is a highly specific “narrow-spectrum” antibiotic, targeting only mycobacteria.

Primary Clinical Uses

  • Active Tuberculosis (TB): Used as a core component of the standard four-drug regimen (alongside Rifampicin, Pyrazinamide, and Ethambutol) to treat pulmonary and extra-pulmonary TB.

  • Latent Tuberculosis Infection (LTBI): Prescribed as monotherapy (usually 300 mg daily for 6–9 months) to prevent the progression of latent TB to active disease in high-risk individuals.

  • Prophylaxis: Given to individuals who have been in close contact with patients having active TB, regardless of their skin test results.

Mechanism of Action

Isoniazid is a prodrug that must be activated by the bacterial enzyme KatG (a catalase-peroxidase).

Inhibition of Mycolic Acid Synthesis: Once activated, it binds to and inhibits the enzyme InhA (enoyl-ACP reductase).

Cell Wall Disruption: This blockade prevents the synthesis of mycolic acids, which are the essential long-chain fatty acids that make up the “waxy” protective cell wall of Mycobacterium tuberculosis.

Bactericidal Effect: For actively dividing bacteria, this loss of cell wall integrity is lethal, making INH highly bactericidal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Isoniazid 300 mg is a high-volume “Essential Medicine” with specific technical requirements:

  • Fixed-Dose Combinations (FDCs): While we manufacture 300 mg single-drug tablets, the global export market (especially via the Global Drug Facility – GDF) heavily favors FDCs like Rifampicin + Isoniazid (150mg/75mg or 300mg/150mg). For your digital platform, showcasing these FDCs is key to attracting B2B buyers.

  • API Purity & Hydrazine Monitoring: During synthesis and storage, INH can degrade into hydrazine, a toxic impurity. As a WHO-GMP firm, we maintain strict assay controls to ensure hydrazine levels remain well below pharmacopeial limits.

  • Stability for Tropical Export: INH is sensitive to moisture and light. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • Pharmacovigilance (Vitamin B6): It is industry standard to recommend co-administration with Pyridoxine (Vitamin B6) to prevent peripheral neuropathy, a common side effect of INH. We often market these as a bundle or a “combipack.”

 

What is indomethacin 25 mg used for?

In the pharmaceutical industry, Indomethacin 25 mg is recognized as one of the most potent Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) of the indole acetic acid class. As a pharmacist, I view Indomethacin as a “heavy-duty” analgesic—while it is highly effective, its potency requires careful monitoring of the gastric and renal systems compared to milder NSAIDs like Ibuprofen.

Primary Clinical Uses

  • Acute Gouty Arthritis: Considered a first-line treatment for managing the intense pain, redness, and swelling of an acute gout attack.

  • Ankylosing Spondylitis: A primary therapy for reducing spinal pain and stiffness in this chronic inflammatory condition.

  • Rheumatoid and Osteoarthritis: Used for moderate to severe cases that do not respond to other NSAIDs.

  • Bursitis and Tendonitis: Effective for acute painful shoulder (calcific tendonitis) or inflammation of the bursa.

  • Patent Ductus Arteriosus (PDA): In a specialized neonatal hospital setting, the injectable form is used to help close a persistent opening in a newborn’s heart.

    Mechanism of Action

Indomethacin is a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2) enzymes.

Prostaglandin Inhibition: It blocks the synthesis of prostaglandins—lipids that act as chemical messengers for pain and inflammation.

Anti-inflammatory Potency: It is significantly more potent than aspirin or ibuprofen in its ability to inhibit prostaglandin synthesis, which is why the 25 mg dose is so effective for severe inflammation.

Antipyretic Effect: Like other NSAIDs, it acts on the hypothalamus to reduce fever.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Indomethacin 25 mg involves specific technical considerations:

  • Gastric Irritation Management: Indomethacin is highly associated with GI upset. As a WHO-GMP manufacturer, we often formulate these as enteric-coated capsules or tablets to protect the stomach lining and ensure the API is released in the small intestine.

  • Solubility & Bioavailability: Indomethacin is a BCS Class II drug (low solubility, high permeability). We utilize micronization of the API and specific surfactants to ensure the 25 mg dose meets BP/USP/IP dissolution standards.

  • Stability for Export: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to protect the product from moisture and light, ensuring a 36-month shelf life for export to Zone IVb regions.

  • B2B & Institutional Supply: Indomethacin is a staple for rheumatology clinics. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration against the innovator (Indocin).

Add to cart